Cogent Biosciences Inc.
COGT | NASDAQ
$32.46
+$0.46 (+1.44%)
Sep 22, 2026, 11:01 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -96.41M | -97.35M | -102.49M | -80.93M | -73.53M | -71.99M | -67.93M | -70.63M | -58.95M | -58.35M | -54.37M | -55.38M | -44.08M | -38.59M | -39.62M | -35.06M | -34.93M | -30.63M | -24.91M | -19.08M | -16.55M | -11.73M |
Depreciation & Amortization | 741K | 1.16M | 1.14M | 1.15M | 1.16M | 1.14M | 1.11M | 1.1M | 1.08M | 1.07M | 794K | 855K | 1.22M | 723K | 937K | 3.71M | 97K | 69K | 68K | 48K | 14K | 17K |
Stock-Based Compensation | 17.11M | 16.91M | 15.75M | 10.6M | 9.72M | 10.01M | 9.98M | 10.36M | 10.01M | 9.39M | 8.85M | 8.76M | 7.16M | 5.85M | 5.04M | 4.62M | n/a | 4.18M | 3.85M | 3.46M | 2.59M | 1.78M |
Other Working Capital | -16.73M | -11.07M | 6.66M | 5.36M | 5.36M | -6.86M | 1.92M | 7.31M | 9.17M | -8.15M | 4.16M | 4.18M | 1.38M | -3.09M | 5.03M | -7.46M | 3.3M | -2.48M | 1.08M | -893K | -243K | -676K |
Other Non-Cash Items | 24.27M | -767K | 6.36M | 133K | 279K | -955K | -2.6M | -6.2M | 2.58M | -1.4M | -4.29M | 909K | -737K | -2.74M | -2.54M | -852K | 5.6M | n/a | n/a | n/a | n/a | -343K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -22.99M | -6.83M | 132K | 4.76M | 7.84M | -4.72M | -1.13M | 13.4M | 2.58M | -3.24M | 4.94M | 6.89M | 4.37M | -4.76M | 6.78M | -6.86M | 2.78M | -1.94M | 215K | 1.46M | 1.43M | -1.09M |
Operating Cash Flow | -77.27M | -86.88M | -79.11M | -64.29M | -54.54M | -66.51M | -60.58M | -51.98M | -42.7M | -52.53M | -44.07M | -37.97M | -32.07M | -39.52M | -29.41M | -34.44M | -26.46M | -28.33M | -20.78M | -14.11M | -12.51M | -11.37M |
Capital Expenditures | -370K | -449K | -811K | -65K | -131K | -547K | -75K | -280K | -148K | -70K | -315K | -121K | -1.26M | -1.1M | -1.97M | -3.31M | -1.14M | -441K | -433K | -1.16M | -123K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 76.4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -82.81M | -133.84M | -395.22M | -224.07M | -67.88M | n/a | -12.72M | -19.47M | -150.4M | -73.01M | -50.92M | -112.47M | -126.4M | -59.01M | -29.62M | -148.23M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 97.46M | 97.83M | 73.26M | 69.09M | 76.92M | 69.93M | 74.47M | 79.93M | 65.92M | 74.13M | 61.72M | 22.06M | 50M | 120M | 60M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -76.4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 14.28M | -36.46M | -322.77M | -155.05M | 8.91M | 69.38M | 61.67M | 60.19M | -84.63M | 1.04M | 10.49M | -90.54M | -77.66M | 59.88M | 28.41M | -151.54M | -1.14M | -441K | -433K | -1.16M | -123K | n/a |
Debt Repayment | n/a | n/a | 168.15M | -235K | 47.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -57K | n/a | -48.9M | n/a | n/a | 720K | n/a | n/a | n/a | 356K | n/a | 1.17M | 102K | n/a | n/a | 1.16M | n/a | n/a | n/a | n/a | n/a | -85K |
Financial Cash Flow | 2.96M | 52.54M | 588.67M | 217.37M | 47.23M | 24.97M | 26K | 624K | -256K | 214.06M | n/a | 1M | 162.09M | 445K | 315K | 990K | 162.12M | 138K | 38.01M | 55K | n/a | -85K |
Net Cash Flow | -60.04M | -70.8M | 186.72M | -2.3M | 1.6M | 27.84M | 1.12M | 8.83M | -127.58M | 162.57M | -33.58M | -127.51M | 52.36M | 20.81M | -682K | -184.99M | 135.77M | -28.64M | 16.8M | -15.22M | -12.63M | -11.45M |
Free Cash Flow | -77.64M | -87.33M | -79.92M | -64.35M | -54.67M | -67.06M | -60.65M | -52.26M | -42.85M | -52.6M | -44.39M | -38.09M | -33.32M | -40.62M | -31.38M | -37.75M | -27.6M | -28.78M | -21.21M | -15.27M | -12.63M | -11.37M |
Adj. Free Cash Flow | -94.75M | -104.24M | -95.67M | -74.96M | -64.39M | -77.07M | -70.63M | -62.62M | -52.86M | -61.99M | -53.24M | -46.85M | -40.49M | -46.47M | -36.41M | -42.37M | -27.6M | -32.95M | -25.06M | -18.74M | -15.22M | -13.15M |
Maintenance CapEx | -370K | -449K | -811K | -65K | -131K | -547K | -75K | -280K | -148K | -70K | -315K | -121K | -1.26M | -1.1M | -1.97M | -3.31M | -1.14M | -441K | -433K | -1.16M | -123K | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -77.64M | -87.33M | -79.92M | -64.35M | -54.67M | -67.06M | -60.65M | -52.26M | -42.85M | -52.6M | -44.39M | -38.09M | -33.32M | -40.62M | -31.38M | -37.75M | -27.6M | -28.78M | -21.21M | -15.27M | -12.63M | -11.37M |
Add to Watchlist
Select watchlists to add or remove COGT